Gefitinib is a leading targeted oral tyrosine kinase inhibitor widely prescribed for non-small cell lung cancer (NSCLC), making it a high-demand essential oncology pharmaceutical across global healthcare markets. As generic gefitinib manufacturing expands across major pharmaceutical hubs, the global trade landscape continues to grow, with consistent B2B procurement demand from licensed pharmaceutical distributors, hospital supply firms, and medical wholesale enterprises worldwide. This definitive guide features a curated, data-backedgefitinib global buyers list, breaking down top importing regions, verified active importer companies, key trade statistics, and critical procurement requirements for international pharmaceutical suppliers. All content adheres to Google’s E-E-A-T guidelines, delivering accurate, actionable, and industry-specific insights for pharmaceutical exporters, manufacturers, and trade…